Results
1 -
10 of
11
(Click
here to explore results)
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 13 Hsp90 Inhibitors in Clinic. Emin Avsar
, 2014
, Pages 336-378
- Natural Product Chemistry for Drug Discovery, Chapter 11 A Snapshot of Natural Product-Derived Compounds in Late Stage Clinical Development at the End of 2008. Mark S. Butler
, 2009
, Pages 321-354
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 12 The Cancer Super-chaperone Hsp90: Drug Targeting and Post-translational Regulation. Annerleim Walton-Diaz, Sahar Khan, Jane B. Trepel, Mehdi Mollapour, Len Neckers
, 2014
, Pages 318-335
- Macrocycles in Drug Discovery, CHAPTER 2 Recent Advances in Macrocyclic Hsp90 Inhibitors. D. M. Ramsey, R. R. A. Kitson, J. I. Levin, C. J. Moody, S. R. McAlpine
, 2015
, Pages 37-77
- Inhibitors of Molecular Chaperones as Therapeutic Agents, Subject Index
, 2014
, Pages 414-425
- Inhibitors of Molecular Chaperones as Therapeutic Agents, Contents
, 2014
, Pages P009-P016
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 1 Overview of Molecular Chaperones in Health and Disease. Tai Wang, Pablo C. EcheverrÃa, Didier Picard
, 2014
, Pages 1-36
- Macrocycles in Drug Discovery, CHAPTER 1 Bioactive Macrocycles from Nature. David J. Newman, Gordon M. Cragg
, 2015
, Pages 1-36
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 4 Exploiting the Dependency of Cancer Cells on Molecular Chaperones. Swee Sharp, Jenny Howes, Paul Workman
, 2014
, Pages 126-157
- Nanomedicines: Design, Delivery and Detection, Chapter 8 Polymeric Nanoparticles and Cancer: Lessons Learnt from CRLX101. Ismael Gritli, Edward Garmey, Scott Eliasof, Andres Tellez, Mark E. Davis, Yen Yun
, 2016
, Pages 199-232